Literature DB >> 9230132

Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase.

S Bédard1, B Marcotte, A Marette.   

Abstract

The principal goal of the present study was to test the hypothesis that cytokines modulate glucose transport in skeletal muscle by increasing nitric oxide production. Cultured L6 skeletal muscle cells were incubated in the presence of tumour necrosis factor-alpha, interferon-gamma or lipopolysaccharide (LPS) alone or in combination for 24 h. Neither cytokines nor LPS alone induced NO production, as measured by nitrite concentrations in the medium. However, when used in combination, the two cytokines significantly stimulated NO production, and this effect was synergistically enhanced by the presence of LPS. Reverse transcriptase-PCR (RT-PCR) analysis revealed that NO release was associated with the induction of inducible (macrophage-type) NO synthase (iNOS). The increase in iNOS expression was confirmed at the protein level by Western-blot analysis and NADPH/diaphorase histochemical staining. Cytokines and LPS markedly increased basal glucose transport in L6 myocytes. Insulin also stimulated basal glucose transport, but significantly less in cells chronically exposed to cytokines/LPS. The sensitivity of L6 muscle cells to insulin-stimulated glucose transport was also significantly decreased by cytokines/LPS treatment. The NOS inhibitor NG-nitro-l-arginine methyl ester (l-NAME) inhibited nitrite production in cytokine/LPS-treated cells, and this prevented the increase in basal glucose transport and restored muscle cell responsiveness to insulin. Cytokines/LPS exposure significantly increased GLUT1 transporter protein levels but decreased GLUT4 expression in L6 cells. l-NAME treatment prevented the increase in GLUT1 protein content but failed to restore GLUT4 transporter levels. These results demonstrate that cytokines and LPS affect glucose transport and insulin action by inducing iNOS expression and NO production in skeletal muscle cells. The data further indicate that cytokines and LPS increase the expression of the GLUT1 transporter protein by an NO-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230132      PMCID: PMC1218586          DOI: 10.1042/bj3250487

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Neuronal NADPH diaphorase is a nitric oxide synthase.

Authors:  B T Hope; G J Michael; K M Knigge; S R Vincent
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Monokine regulation of glucose transporter mRNA in L6 myotubes.

Authors:  P Cornelius; M D Lee; M Marlowe; P H Pekala
Journal:  Biochem Biophys Res Commun       Date:  1989-11-30       Impact factor: 3.575

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells.

Authors:  D Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

5.  Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA.

Authors:  S Liu; I M Adcock; R W Old; P J Barnes; T W Evans
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

6.  Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.

Authors:  J M Stephens; P H Pekala
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

7.  Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells.

Authors:  T Tsakiridis; H E McDowell; T Walker; C P Downes; H S Hundal; M Vranic; A Klip
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

8.  Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite.

Authors:  C P Verdon; B A Burton; R L Prior
Journal:  Anal Biochem       Date:  1995-01-20       Impact factor: 3.365

9.  Short-term effects of tumor necrosis factor on energy and substrate metabolism in dogs.

Authors:  Y Sakurai; X U Zhang; R R Wolfe
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

Authors:  W M Moore; R K Webber; G M Jerome; F S Tjoeng; T P Misko; M G Currie
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

View more
  28 in total

1.  Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds.

Authors:  Eric Mahoney; Jonathan Reichner; Leslie Robinson Bostom; Balduino Mastrofrancesco; William Henry; Jorge Albina
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.

Authors:  Adem Kalender; Anand Selvaraj; So Young Kim; Pawan Gulati; Sophie Brûlé; Benoit Viollet; Bruce E Kemp; Nabeel Bardeesy; Patrick Dennis; John J Schlager; André Marette; Sara C Kozma; George Thomas
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

Review 3.  Justification for antioxidant preconditioning (or how to protect insulin-mediated actions under oxidative stress).

Authors:  A Orzechowski
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

4.  Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha.

Authors:  Malcolm Grohmann; Emily Foulstone; Gavin Welsh; Jeff Holly; Julian Shield; Elizabeth Crowne; Claire Stewart
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

5.  Nitric oxide synthase isoforms I, III and protein kinase-Ctheta in skeletal muscle fibres of normal and streptozotocin-induced diabetic rats with and without Ginkgo biloba extract treatment.

Authors:  K Punkt; S Zaitsev; J K Park; M Wellner; I B Buchwalow
Journal:  Histochem J       Date:  2001-04

6.  NO synthase II in mouse skeletal muscle is associated with caveolin 3.

Authors:  I Gath; J Ebert; U Gödtel-Armbrust; R Ross; A B Reske-Kunz; U Förstermann
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 7.  Hyperglycemia in critical illness: a review.

Authors:  David Brealey; Mervyn Singer
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

8.  Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction.

Authors:  H F Brooks; C K Osabutey; R F Moss; P L R Andrews; D C Davies
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

9.  Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.

Authors:  Michael Shum; Kerstin Bellmann; Philippe St-Pierre; André Marette
Journal:  Diabetologia       Date:  2016-01-05       Impact factor: 10.122

10.  Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge.

Authors:  Frédéric Picard; Denis Arsenijevic; Denis Richard; Yves Deshaies
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.